Moderna ready to invest in S’pore as it seeks to raise Asia-Pac headcount to 200 by end-2023
SINGAPORE - Biotechnology firm Moderna has committed to investing in Singapore and the region, with plans to grow its Asia-Pacific headcount from 80 to 200 by the end of 2023.
On Monday, the American company announced its new Singapore general manager, Ms Evelyn Pang, who will head and grow its Singapore office. She will be setting up a team to oversee a range of functions to support commercial and medical activities in the market.
莫德纳设新加坡子公司 彭敏儿受委为总经理
订户
制药公司莫德纳（Moderna）宣布成立新加坡子公司，并委任彭敏儿为新加坡总经理。
莫德纳星期一（12月12日）发文告指出，彭敏儿将负责创建公司在新加坡的业务和活动，以及设立团队监督公司进展，支持公司的商业和医疗活动。
彭敏儿在医疗保健领域有17年工作经验，加入莫德纳前，她任职于裕利药剂（Zuellig Pharma），是ZP Therapeutics的总经理。
没有评论:
发表评论